Can a pill prevent HIV? Negotiating the biomedicalisation of HIV prevention. - Wikidata - awgldk - TriplyDB

Can a pill prevent HIV? Negotiating the biomedicalisation of HIV prevention.

Can a pill prevent HIV? Negotiating the biomedicalisation of HIV prevention.

http://www.wikidata.org/entity/Q37404649

about

Risk, reassurance and routine: a qualitative study of narrative understandings of the potential for HIV self-testing among men who have sex with men in England.Science, technology, power and sex: PrEP and HIV-positive gay men in Paris.DIY HIV prevention: Formative qualitative research with men who have sex with men who source PrEP outside of clinical trials

P2860

Q33716554-FFD3C9C4-5385-4622-B610-0B23CE3013A9 Q38918530-07D21473-2516-4ED3-A677-B3C3AE43537A Q57180013-E9799985-514A-4AC0-9102-3F90C5AA7A83

P2860

Can a pill prevent HIV? Negotiating the biomedicalisation of HIV prevention.

http://www.wikidata.org/entity/Q37404649

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 October 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Can a pill prevent HIV? Negotiating the biomedicalisation of HIV prevention.

@en

Can a pill prevent HIV? Negotiating the biomedicalisation of HIV prevention.

@nl

type

label

Can a pill prevent HIV? Negotiating the biomedicalisation of HIV prevention.

@en

Can a pill prevent HIV? Negotiating the biomedicalisation of HIV prevention.

@nl

prefLabel

Can a pill prevent HIV? Negotiating the biomedicalisation of HIV prevention.

@en

Can a pill prevent HIV? Negotiating the biomedicalisation of HIV prevention.

@nl

P1433

Q37404649-28ECB29C-FBB5-40A9-BE8E-EF743902818C

P1476

Q37404649-E0E834D6-CB2C-47A0-9A6F-CB1A798D8462

P2093

Q37404649-38994457-9CF4-4DBB-970C-7EF57CC59EBE

Q37404649-42E885C2-D172-4FF7-9D14-B15D7836CF12

Q37404649-C613C185-C235-42B3-AA57-0E2C28ACA0FC

P2860

Q37404649-031DAF55-C033-4E79-9889-924C0176579D

Q37404649-14D4B1A5-1E59-48C7-8946-D3044EDA6C5B

Q37404649-350EFAA2-C933-46C3-BEED-3625685F29C2

Q37404649-3F70339A-FE7D-4F95-9765-E65BA099103E

Q37404649-4CCB5249-AD59-43F9-ABAB-74DC83BC4328

Q37404649-51A74112-564A-484D-8A94-DFE165012F98

Q37404649-5ADF917D-01C5-4E64-A242-A7A4802972DA

Q37404649-628984B6-F2A1-4DD7-8519-39539F9502F4

Q37404649-6F725741-EE35-4CDE-AC6C-74BC0232B217

Q37404649-77524EE2-3732-4E2B-8189-ACB7A4A94B89

P304

Q37404649-C638A0C5-ED53-492E-A7D2-E6E893FB921E

P31

Q37404649-AD85B294-3159-44B9-8FA4-98150247B376

P356

Q37404649-815356F9-F063-435C-A897-7145F2FCF8A5

P433

Q37404649-C92B2F09-1677-42E3-8B00-93A8FA8391DC

P478

Q37404649-02D62221-972F-4500-BE25-858DC98B58FB

P50

Q37404649-061CFBF1-CE5E-4751-A05E-FE538A2017E8

Q37404649-0BCC73C8-2083-4CD5-A6BC-3E4BBE046056

Q37404649-F71EB419-CE7F-41BA-B1DE-369B0D1422EC

P577

Q37404649-6B58B521-DB79-4588-AD7D-912FCCA2D5FF

P5875

Q37404649-5FAD0335-4E27-4ACD-8665-87A8527C7D18

P698

Q37404649-649042BE-08AD-4FDD-9124-A36545EABCCF

P921

Q37404649-74790C8D-8EE8-47DE-B7E4-B8C4C48FF800

Q37404649-D13A2239-C0E1-42D9-8000-0EC44DBDBB67

P932

Q37404649-BB77E43A-1DA7-4610-BA54-19700168B547

P356

1467-9566.12372

P1433

Sociology of Health and Illness

P1476

Can a pill prevent HIV? Negotiating the biomedicalisation of HIV prevention

@en

P2093

Ingrid Young

http://www.w3.org/2001/XMLSchema#string

Lisa McDaid

http://www.w3.org/2001/XMLSchema#string

Paul Flowers

http://www.w3.org/2001/XMLSchema#string

P2860

Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.

Sustaining safe practice: twenty years on.

HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making.

Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland

HIV treatment as prevention and HPTN 052.

Use of antiretrovirals for HIV prevention: what do we know and what don't we know?

What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples.

How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention.

Configuring the users of new HIV-prevention technologies: the case of HIV pre-exposure prophylaxis.

Acceptability of PrEP for HIV prevention among women at high risk for HIV.

P304

411-425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1467-9566.12372

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283213918

http://www.w3.org/2001/XMLSchema#string

P698

26498141

http://www.w3.org/2001/XMLSchema#string

P921

prevention of HIV/AIDS

P932

5102670

http://www.w3.org/2001/XMLSchema#string